Lexicon Pharmaceuticals | LXRX - Trade Debtors

Stock Price
1.31
Daily Change
0 0%
Monthly
5.65%
Yearly
66.90%
Q1 Forecast
2.01

Lexicon Pharmaceuticals reported $2.62M in Trade Debtors for its fiscal quarter ending in June of 2024.





Trade Debtors Change Date
Abbott USD 10.4B 166M Sep/2025
Acadia Pharmaceuticals USD 139.44M 19.75M Sep/2025
Agios Pharmaceuticals USD 10.58M 5.55M Dec/2025
Akebia Therapeutics USD 61.54M 27.17M Mar/2025
Alnylam Pharmaceuticals USD 777.57M 187.2M Dec/2025
AstraZeneca USD 19.05B 1.49B Dec/2025
BioMarin Pharmaceutical USD 790.27M 65.59M Sep/2025
Coherus Biosciences USD 62.44M 59.9M Mar/2025
Eli Lilly USD 19.46B 2.25B Sep/2025
Esperion Therapeutics USD 60.36M 5.75M Jun/2024
Halozyme Therapeutics USD 346.04M 29.7M Sep/2025
Illumina USD 854M 125M Dec/2025
Insmed USD 65.26M 10.23M Sep/2025
Ironwood Pharmaceuticals USD 81.89M 5.68M Dec/2024
J&J USD 17.61B 235M Sep/2025
Lexicon Pharmaceuticals USD 2.62M 1.09M Jun/2024
MacroGenics USD 69.23M 56.7M Sep/2025
MannKind USD 17.38M 9.76M Sep/2025
Merck USD 12.12B 596M Sep/2025
Moderna USD 184M 862M Dec/2025
Novartis USD 8.98B 192M Sep/2025
PTC Therapeutics USD 203.07M 6.94M Sep/2025
Puma Biotechnology USD 28.1M 3.52M Jun/2024
Sarepta Therapeutics USD 395.74M 213.86M Sep/2025
Thermo Fisher Scientific USD 8.9B 11M Dec/2025
Ultragenyx Pharmaceutical USD 112.54M 11.92M Sep/2025
United Therapeutics USD 297.7M 81.6M Sep/2025
Vanda Pharmaceuticals USD 47.1M 4.35M Dec/2024